Cargando…

Mesenchymal Stromal Cell Therapy in Ischemia/Reperfusion Injury

Ischemia/reperfusion injury (IRI) represents a worldwide public health issue of increasing incidence. IRI may virtually affect all organs and tissues and is associated with significant morbidity and mortality. Particularly, the duration of blood supply deprivation has been recognized as a critical f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rowart, Pascal, Erpicum, Pauline, Detry, Olivier, Weekers, Laurent, Grégoire, Céline, Lechanteur, Chantal, Briquet, Alexandra, Beguin, Yves, Krzesinski, Jean-Marie, Jouret, François
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4518154/ https://www.ncbi.nlm.nih.gov/pubmed/26258151 http://dx.doi.org/10.1155/2015/602597

Ejemplares similares

Administration of mesenchymal stromal cells before renal ischemia/reperfusion attenuates kidney injury and may modulate renal lipid metabolism in rats
por: Erpicum, Pauline, et al.
Publicado: (2017)

Mesenchymal Stromal Cells Accelerate Epithelial Tight Junction Assembly via the AMP-Activated Protein Kinase Pathway, Independently of Liver Kinase B1
por: Rowart, P., et al.
Publicado: (2017)

Clinical-scale expansion of mesenchymal stromal cells: a large banking experience
por: Lechanteur, Chantal, et al.
Publicado: (2016)

Effect of the Combination of Everolimus and Mesenchymal Stromal Cells on Regulatory T Cells Levels and in a Liver Transplant Rejection Model in Rats
por: Vandermeulen, Morgan, et al.
Publicado: (2022)

Bone Marrow-Derived Mesenchymal Stromal Cell Therapy in Severe COVID-19: Preliminary Results of a Phase I/II Clinical Trial
por: Grégoire, Céline, et al.
Publicado: (2022)

Comparison of Mesenchymal Stromal Cells From Different Origins for the Treatment of Graft-vs.-Host-Disease in a Humanized Mouse Model
por: Grégoire, Céline, et al.
Publicado: (2019)

Two novel mutations of the CLDN16 gene cause familial hypomagnesaemia with hypercalciuria and nephrocalcinosis
por: Hanssen, Oriane, et al.
Publicado: (2014)

Non-invasive approaches in the diagnosis of acute rejection in kidney transplant recipients, part II: omics analyses of urine and blood samples
por: Erpicum, Pauline, et al.
Publicado: (2017)

Non-invasive approaches in the diagnosis of acute rejection in kidney transplant recipients. Part I. In vivo imaging methods
por: Hanssen, Oriane, et al.
Publicado: (2017)

MSC Manufacturing for Academic Clinical Trials: From a Clinical-Grade to a Full GMP-Compliant Process
por: Lechanteur, Chantal, et al.
Publicado: (2021)

Nuclear Magnetic Resonance Metabolomic Profiling of Mouse Kidney, Urine and Serum Following Renal Ischemia/Reperfusion Injury
por: Jouret, François, et al.
Publicado: (2016)

Multipotent mesenchymal stromal cells as treatment for poor graft function after allogeneic hematopoietic cell transplantation: A multicenter prospective analysis
por: Servais, Sophie, et al.
Publicado: (2023)

Controversies in the management of the haemodialysis-related arteriovenous fistula following kidney transplantation
por: Vanderweckene, Pauline, et al.
Publicado: (2018)

Mesenchymal stromal cells in renal ischemia/reperfusion injury
por: de Vries, Dorottya K., et al.
Publicado: (2012)

Implications of AMPK in the Formation of Epithelial Tight Junctions
por: Rowart, Pascal, et al.
Publicado: (2018)

Infusion of bone marrow derived multipotent mesenchymal stromal cells for the treatment of steroid-refractory acute graft-versus-host disease: a multicenter prospective study
por: Servais, Sophie, et al.
Publicado: (2018)

Protéinurie chez les patients atteints de la COVID-19 : prévalence, caractérisation et rôle pronostique
por: Huart, J., et al.
Publicado: (2020)

“Acute kidney dysfunction with no rejection” is associated with poor renal outcomes at 2 years post kidney transplantation
por: Paquot, François, et al.
Publicado: (2019)

Corrélation anatomoclinique de l’atteinte rénale de la COVID-19
por: Bouquegneau, A., et al.
Publicado: (2020)

IL-37 Gene Modification Enhances the Protective Effects of Mesenchymal Stromal Cells on Intestinal Ischemia Reperfusion Injury
por: Kong, Dejun, et al.
Publicado: (2020)

Role of Mesenchymal Stem/Stromal Cells in Modulating Ischemia/Reperfusion Injury: Current State of the Art and Future Perspectives
por: Miceli, Vitale, et al.
Publicado: (2023)

Adenosine Production by Biomaterial‐Supported Mesenchymal Stromal Cells Reduces the Innate Inflammatory Response in Myocardial Ischemia/Reperfusion Injury
por: Shin, Eric Y., et al.
Publicado: (2018)

Topical Application of Mesenchymal Stromal Cells Ameliorated Liver Parenchyma Damage After Ischemia-Reperfusion Injury in an Animal Model
por: Lam, Ping Kuen, et al.
Publicado: (2017)

Bone Marrow-Derived Mesenchymal Stem Cells Drive Lymphangiogenesis
por: Maertens, Ludovic, et al.
Publicado: (2014)

Observer variability in the assessment of renal (18)F-FDG uptake in kidney transplant recipients
por: Jadoul, Alexandre, et al.
Publicado: (2020)

Cryopreserved Mesenchymal Stromal Cells Maintain Potency in a Retinal Ischemia/Reperfusion Injury Model: Toward an off-the-shelf Therapy
por: Gramlich, Oliver W., et al.
Publicado: (2016)

PPARβ/δ priming enhances the anti-apoptotic and therapeutic properties of mesenchymal stromal cells in myocardial ischemia–reperfusion injury
por: Sarre, Charlotte, et al.
Publicado: (2022)

Adipose-Derived Mesenchymal Stromal/Stem Cell Line Prevents Hepatic Ischemia/Reperfusion Injury in Rats by Inhibiting Inflammasome Activation
por: Chen, Kaili, et al.
Publicado: (2022)

Genetic susceptibility to delayed graft function following kidney transplantation: a systematic review of the literature
por: Huart, Justine, et al.
Publicado: (2018)

Urinary and dietary sodium and potassium associated with blood pressure control in treated hypertensive kidney transplant recipients: an observational study
por: Saint-Remy, Annie, et al.
Publicado: (2012)

The Effect of Elective Ligation of the Arteriovenous Fistula on Cardiac and Renal Functions in Kidney Transplant Recipients
por: Masson, Grégoire, et al.
Publicado: (2023)

Autophagy and Liver Ischemia-Reperfusion Injury
por: Cursio, Raffaele, et al.
Publicado: (2015)

Comparison of human adipose stromal vascular fraction and adipose-derived mesenchymal stem cells for the attenuation of acute renal ischemia/reperfusion injury
por: Zhou, Liuhua, et al.
Publicado: (2017)

Correction: PPARβ/δ priming enhances the anti-apoptotic and therapeutic properties of mesenchymal stromal cells in myocardial ischemia–reperfusion injury
por: Sarre, Charlotte, et al.
Publicado: (2022)

PDGFRα/Sca-1 Sorted Mesenchymal Stromal Cells Reduce Liver Injury in Murine Models of Hepatic Ischemia-Reperfusion Injury
por: Owen, Andrew, et al.
Publicado: (2022)

Imatinib and Nilotinib Inhibit Hematopoietic Progenitor Cell Growth, but Do Not Prevent Adhesion, Migration and Engraftment of Human Cord Blood CD34(+) Cells
por: Belle, Ludovic, et al.
Publicado: (2012)

Serum levels of carbohydrate antigen 19-9 do not systematically increase in case of liver cyst infection in patients with autosomal dominant polycystic kidney disease
por: Neuville, Marie F, et al.
Publicado: (2019)

Mesenchymal stromal cell-derived extracellular vesicles attenuate lung ischemia-reperfusion injury and enhance reconditioning of donor lungs after circulatory death
por: Stone, Matthew L., et al.
Publicado: (2017)

Therapeutic Properties of Mesenchymal Stem Cell on Organ Ischemia-Reperfusion Injury
por: Oliva, Joan
Publicado: (2019)

Increase in Cardiac Ischemia-Reperfusion Injuries in Opa1(+/-) Mouse Model
por: Le Page, Sophie, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ad3bkbfsoptdv49bvdk97mbtlq